RAS-Q technology wins third price for best poster at European Society of Artificial Organs

Tom Verbelen (Leuven, Belgium), who performed the animal trials of the RAS-Q® technology, won the third prize for best poster at the annual European Society of Aritficial Organs (ESAO) congress for the “in-vivo study of a novel lung support device for PAH and bridge-to-transplant/candidacy”. The results of this study demonstrate RAS-Q®’s capability as a bridge-to-transplant device for patients with severe lung diseases. The trial showed that its unique low pressure loss and integrated compliance allow RAS-Q® to react and adapt to the patient needs.